CNC

Centene’s Q3 earnings could be pressured by falling memberships and higher costs, but better margins and a strong stock rally give some upside. Investors may weigh these factors when deciding to buy, sell or hold.

Centene, Oscar, and UnitedHealthcare are expanding into new ACA counties in 2027, while other insurers are pulling out of exchanges. Centene and UnitedHealthcare are covering larger state exits with their new entries.

Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 third quarter financial results at approximately 6:00 a.m. ET on Tuesday, October 27, 2026, and host a conference call at 8:30 a.m. ET to review the results.

Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced the expansion of its CHOICE Arrangements benefit program (formerly ICHRA) to employees in Ohio and Oklahoma for plan year 2027.

Centene lifted its full‑year adjusted EPS guidance above $4.80, thanks to stronger Marketplace and Medicare Part D margins. The move suggests the company’s turnaround still has room to grow.

Centene remains a Buy, supported by operational improvements, disciplined capital management, and a discounted valuation vs. sector averages. Learn more about CNC stock here.

Centene’s nationwide Gold Card program is designed to simplify prior authorization and reduce admin costs. Whether it delivers real savings depends on how widely it is adopted.

Centene CEO Sarah London said she joined the company to fix health care, not because she thought it was already working well. She is the youngest female Fortune 500 chief executive.